Charles River Newsroom

Charles River Labs Price Target Announced at $167.00/Share by CLSA

Dow JonesOct 23 06:56 ET

Charles River Analyst Ratings

BenzingaOct 23 06:47 ET

Charles River Initiated With an Underperform at CLSA

TipRanksOct 23 06:27 ET

Barclays Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $205

Moomoo NewsOct 16 05:31 ET

J.P. Morgan Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $195

Moomoo NewsOct 15 08:36 ET

Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Nurix Therapeutics (NRIX) and Charles River Labs (CRL)

TipRanksOct 15 08:15 ET

Barclays Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $205

Moomoo NewsOct 15 07:31 ET

Charles River Analyst Ratings

BenzingaOct 14 12:14 ET

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $240 From $250, Maintains Buy Rating

MT NewswiresOct 8 09:53 ET

Charles River Labs Price Target Cut to $190.00/Share From $225.00 by Evercore ISI Group

Dow JonesOct 7 07:51 ET

Charles River Analyst Ratings

BenzingaOct 7 07:42 ET

Evercore Downgrades Charles River(CRL.US) to Hold Rating

Moomoo NewsOct 7 06:32 ET

Evercore ISI Downgrades Charles River Labs (CRL) to a Hold

TipRanksOct 7 06:29 ET

BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $215

Moomoo NewsOct 2 10:31 ET

BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $215

Moomoo NewsOct 2 06:31 ET

Charles River Downgraded to Neutral From Buy at BofA

TipRanksOct 2 06:12 ET

Bio-Rad Upped by Citi to Buy; Charles River, Hologic Downgraded

Seeking AlphaOct 1 18:38 ET

Charles River Analyst Ratings

BenzingaOct 1 09:29 ET

Citi Downgrades Charles River(CRL.US) to Sell Rating, Cuts Target Price to $175

Moomoo NewsOct 1 06:31 ET

Evercore Maintains Charles River(CRL.US) With Buy Rating, Maintains Target Price $225

Moomoo NewsSep 25 08:31 ET